Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. (Q40864473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

review article

1 reference

title

Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

G H McCracken

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

language of work or name

English

0 references

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

497-508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

The pathogenesis of sepsis

11 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Detection of circulating tumor necrosis factor after endotoxin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Tumor necrosis factor and the acute metabolic response to tissue injury in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Shock and tissue injury induced by recombinant human cachectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Correlation of plasma cytokine elevations with mortality rate in children with sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Cardiovascular Effects of Endogenous Opiate Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Colony-stimulating factors and host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Adhesion receptors of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Integrins: a family of cell surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Neutrophils and host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Shock in the pediatric patient. Part II. Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Gram-negative bacteremia. The current setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Steroids in the treatment of clinical septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Naloxone versus placebo in treatment of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Effects of prolonged naloxone infusion in septic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Monoclonal antibody to TNF in severe septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Interleukin 1 receptor blockade attenuates the host inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Pentoxifylline prevents tumor necrosis factor-induced lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Oxpentifylline in endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Inhaled nitric oxide for the adult respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

Current perspectives on septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Septic shock in children: bacterial etiologies and temporal relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

inferred from DOI database lookup

7 January 2021

based on heuristic

The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980942-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)80942-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8410500%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference